CTI BioPharma Corp. (NASDAQ:CTIC)

About the company

CTI BioPharma Corp. is a biopharmaceutical company, which focuses on the development, acquisition and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

25

CEO

Adam R. Craig

Exchange

NASDAQ

Website

http://www.ctibiopharma.com

$3.00M

Total Revenue

25

Employees

$71.98M

Market Capitalization

-1.74

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$3M

Operating Margin (in %)

Total operating margin

$-4M

Net Margin (in %)

Total net margin

$-3M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12018.30 1376.00 5.12 18.95 43.06
Catalent, Inc. CTLT 11623.49 2872.00 5.84 111.44 3.63
Perrigo Co. Plc PRGO 7607.61 4837.00 1.30 51.90 3.02
Jazz Pharmaceuticals Plc JAZZ 6076.20 2188.00 2.10 22.21 12.81
Bausch Health Cos., Inc. BHC 6068.07 8597.00 8.47 -3.21 -21.96
United Therapeutics Corp. UTHR 4985.85 1443.00 1.73 9.62 36.59
MyoKardia, Inc. MYOK 4168.52 34.00 12.11 -13.45 -201.73
Axsome Therapeutics, Inc. AXSM 2906.40 None 19.72 -32.31 None
Pacira Biosciences, Inc. PCRX 2427.60 435.00 6.51 -5780.00 -0.02
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
SAGE Therapeutics, Inc. SAGE 2138.76 9.00 2.51 -3.30 -413.06
Corcept Therapeutics, Inc. CORT 2013.00 335.00 4.62 18.97 31.64
Prestige Consumer Healthcare, Inc. PBH 1863.54 963.00 1.57 13.14 14.77
Revolution Medicines, Inc. RVMD 1798.91 48.00 4.67 -25.41 -146.29
Madrigal Pharmaceuticals, Inc. MDGL 1558.65 0.00 4.16 -15.26 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1548.02 440.00 -21.91 18.26 19.14
Innoviva, Inc. INVA 1544.71 285.00 3.66 7.99 66.41
Intercept Pharmaceuticals, Inc. ICPT 1440.96 272.00 -42.89 -4.20 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Supernus Pharmaceuticals, Inc. SUPN 1309.50 402.00 2.08 11.23 28.90
Theravance Biopharma, Inc. TBPH 1208.97 88.00 -8.48 -4.90 -280.80
Zogenix, Inc. ZGNX 1192.05 5.00 3.25 -2.80 -241.62
Revance Therapeutics, Inc. RVNC 1161.84 0.00 4.59 -6.23 41.82
Amphastar Pharmaceuticals, Inc. AMPH 996.66 327.00 2.49 19.56 15.90
Endo International Plc ENDP 775.20 3014.00 -1.06 -2.76 -9.09
BellRing Brands, Inc. BRBR 762.45 954.00 -0.41 5.78 13.98
Eagle Pharmaceuticals, Inc. EGRX 678.30 192.00 3.65 269.17 1.29
Assembly Biosciences, Inc. ASMB 667.58 16.00 2.99 -6.71 -601.75
Aerie Pharmaceuticals, Inc. AERI 638.73 79.00 5.07 -3.16 -252.92
Intersect ENT, Inc. XENT 577.76 102.00 5.45 -11.57 -48.61
Collegium Pharmaceutical, Inc. COLL 577.66 299.00 4.13 -44.71 -4.21
Catalyst Pharmaceuticals, Inc. CPRX 533.93 119.00 5.20 12.17 36.09
Anika Therapeutics, Inc. ANIK 494.90 125.00 1.71 17.85 22.73
BioDelivery Sciences International, Inc. BDSI 381.34 130.00 5.45 -51.81 -5.01
ANI Pharmaceuticals, Inc. ANIP 334.80 203.00 1.71 -214.62 -0.67
Albireo Pharma, Inc. ALBO 326.82 11.00 3.32 -4.28 -730.55
MEI Pharma, Inc. MEIP 275.56 5.00 4.74 -7.06 -539.48
Mallinckrodt Plc MNK 212.52 3037.00 0.11 -0.18 -39.56
Marinus Pharmaceuticals, Inc. MRNS 146.79 0.00 5.68 -2.18 None
Agile Therapeutics, Inc. AGRX 140.12 None 2.28 -6.79 None
Cerecor, Inc. CERC 118.22 7.00 7.56 -5.24 -429.22
Ampio Pharmaceuticals, Inc. AMPE 98.67 1.00 69.00 -5.31 None
Zynerba Pharmaceuticals, Inc. ZYNE 85.79 0.00 1.41 -2.39 -699.94
AcelRx Pharmaceuticals, Inc. ACRX 84.80 2.00 -1.56 -1.51 -644.25
Aclaris Therapeutics, Inc. ACRS 81.18 4.00 1.42 -0.59 None
Cassava Sciences, Inc. SAVA 76.66 41.00 4.03 -16.81 76.71
Adamas Pharmaceuticals, Inc. ADMS 75.32 57.00 -4.80 -0.81 -160.44
CTI BioPharma Corp. CTIC 71.98 3.00 3.21 -1.74 -111.83
Oramed Pharmaceuticals, Inc. ORMP 59.94 3.00 4.83 -4.69 -464.15
Cumberland Pharmaceuticals, Inc. CPIX 47.70 47.00 0.97 -10.60 -9.59
Natural Alternatives International, Inc. NAII 47.67 114.00 0.65 -12.61 -3.19
SCYNEXIS, Inc. SCYX 46.41 0.00 9.75 -1.20 -30.84
IsoRay, Inc. ISR 44.22 9.00 8.25 -13.20 -36.08
Lipocine, Inc. LPCN 40.20 0.00 9.57 -2.68 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 32.50 65.00 -2.50 -1.86 -26.74
PLx Pharma, Inc. PLXP 26.19 0.00 -2.51 -2.77 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
Evoke Pharma, Inc. EVOK 20.58 397.00 0.05 -7.15 -0.76
EyeGate Pharmaceuticals, Inc. EYEG 19.92 3.00 2.48 -1.68 -264.21
Regulus Therapeutics, Inc. RGLS 15.96 0.00 1.41 -0.75 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 11.90 8.00 0.63 -0.14 -798.18
Intec Pharma Ltd. NTEC 10.18 None 1.31 -0.24 None
Hepion Pharmaceuticals, Inc. HEPA 7.50 None 2.34 -0.63 None
Sonoma Pharmaceuticals, Inc. SNOA 6.44 19.00 1.02 -2.06 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
VIVUS, Inc. VVUS 5.83 73.00 -0.13 -0.20 -39.28
Tonix Pharmaceuticals Holding Corp. TNXP 4.48 None 1.12 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Here is What Hedge Funds Think About CTI Biopharma Corp. (CTIC)

21d ago, source: YAHOO!

In this article we will check out the progression of hedge fund sentiment towards CTI Biopharma Corp. (NASDAQ:CTIC) and ...

CTI BioPharma Corp CEPS

7d ago, source: Morningstar%2c Inc.

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...

CTI BioPharma (NASDAQ:CTIC) Rating Reiterated by Lake Street Capital

7d ago, source: theenterpriseleader.com

Lake Street Capital reissued their market perform rating on shares of CTI BioPharma (NASDAQ:CTIC) in a report released on ...

CTIC CTI BioPharma Corp. (DE) Common Stock

18d ago, source: Nasdaq

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

CTI BioPharma Announces Enrollment of First Patient in COVID-19 PRE-VENT Phase 3 Clinical Trial

12d ago, source: Bloomberg

Before it's here, it's on the Bloomberg Terminal.

CTI BioPharma to Present at the Jefferies 2020 Healthcare Conference on Thursday, Jun. 4

1mon ago, source: Skagit Valley Herald

About CTI BioPharma Corp. We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a ...

20 Healthcare Stocks Moving In Wednesday's Pre-Market Session

26d ago, source: MSN

electroCore, Inc. (NASDAQ:ECOR) stock increased by 10.59% to $1.07. The most recent rating by H.C. Wainwright, on Mar 24, is at Buy, with a price target of $2. • CTI BioPharma, Inc. (NASDAQ ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.